Meta-analysis of 49 549 individuals imputed with the 1000 Genomes Project reveals an exonic damaging variant in ANGPTL4 determining fasting TG levels
暂无分享,去创建一个
Marcelo P. Segura-Lepe | P. Elliott | O. Franco | A. Hofman | A. Uitterlinden | T. Lehtimäki | E. Boerwinkle | V. Salomaa | V. Gudnason | J. Viikari | A. Sabo | I. Borecki | Albert Vernon Smith | O. Raitakari | A. Dehghan | F. Rivadeneira | B. Psaty | B. Penninx | G. Willemsen | E. D. de Geus | T. Harris | D. Arking | S. Ripatti | H. Snieder | R. Cooper | P. Harst | J. Rotter | T. Harris | I. Rudan | D. Boomsma | E. D. de Geus | M. Swertz | J. Brody | K. Rice | I. Surakka | A. Isaacs | A. D. de Craen | J. Deelen | E. V. van Leeuwen | P. Slagboom | C. V. van Duijn | L. Cupples | J. Jukema | James G. Wilson | J. Bis | J. Kooner | S. Rich | L. Hocking | C. Hayward | P. Joshi | I. Kolčić | O. Polašek | V. Vitart | H. Campbell | M. Kähönen | James F. Wilson | M. Feitosa | J. Marten | A. Campbell | I. Nolte | S. Padmanabhan | B. Tayo | P. J. van der Most | Weihua Zhang | R. de Mutsert | Q. Duan | E. Evangelou | T. Forrester | B. Lehne | C. Mckenzie | Y. Milaneschi | W. Scott | J. Chambers | A. Oldehinkel | P. van der Harst | D. Mook-Kanamori | A. Morrison | E. Sijbrands | L. Lyytikäinen | J. Jukema | C. Duijn | P. Navarro | Charles White | S. Trompet | S. W. van der Laan | N. Verweij | I. Ford | R. Gansevoort | G. Pasterkamp | L. Lange | R. Li-Gao | K. Nikus | E. D. Geus | S. W. Laan | A. Craen | Sian-Tsung Tan | H. Mbarek | A. Manichaikul | J. Mychaleckyj | T. Zemunik | E. M. Leeuwen | J. Huffman | S. Demissie | K. V. Dijk | R. Mutsert | P. J. Most | K. Willems van Dijk | J. V. van Klinken | Jennifer A. Brody | Peter J. van der Most | A. Kooner | Hester M de Ruijter | S. Rich | Terrence G. Forrester | A. Smith | O. Raitakari | James F. Wilson | A. Hofman | P. van der harst | S. Tan | Hester M de Ruijter | Terrence Forrester | A. Smith | Angad S Kooner | Weihua Zhang | M. Kähönen | A. Uitterlinden | C. McKenzie | P. Slagboom | D. Boomsma | B. Psaty | Charles White | J. B. V. Klinken | Hester M de Ruijter | Olli T. Raitakari | A. Campbell | A. de Craen | Cornelia M. Van Duijn | Hester M de Ruijter | R. Cooper
[1] Sara M. Willems,et al. The impact of low-frequency and rare variants on lipid levels , 2015, Nature Genetics.
[2] Pieter B. T. Neerincx,et al. Genome of the Netherlands population-specific imputations identify an ABCA6 variant associated with cholesterol levels , 2015, Nature communications.
[3] David M. Herrington,et al. Multiple rare alleles at LDLR and APOA5 confer risk for early-onset myocardial infarction , 2014, Nature.
[4] E. Zeggini,et al. The African Genome Variation Project shapes medical genetics in Africa , 2014, Nature.
[5] J. Buitelaar,et al. Cohort Profile Update: The TRacking Adolescents’ Individual Lives Survey (TRAILS) , 2014, International journal of epidemiology.
[6] John Spertus,et al. Inactivating mutations in NPC1L1 and protection from coronary heart disease. , 2014, The New England journal of medicine.
[7] He Zhang,et al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. , 2014, The New England journal of medicine.
[8] Alex P. Reiner,et al. Loss-of-Function Mutations in APOC 3 , Triglycerides , and Coronary Disease , 2014 .
[9] Abstr Act,et al. Inactivating Mutations in NPC1L1 and Protection from Coronary Heart Disease , 2014 .
[10] Inactivating Mutations in NPC 1 L 1 and Protection from Coronary Heart Disease , 2014 .
[11] Tanya M. Teslovich,et al. Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.
[12] Margreet Kloppenburg,et al. The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection , 2013, European Journal of Epidemiology.
[13] Meike W. Vernooij,et al. The Rotterdam Study: 2014 objectives and design update , 2013, European Journal of Epidemiology.
[14] M. McCarthy,et al. Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes , 2012, Diabetologia.
[15] J. Marchini,et al. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing , 2012, Nature Genetics.
[16] N. Sattar,et al. Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses , 2011, BMC Medical Genetics.
[17] Michele Magrane,et al. UniProt Knowledgebase: a hub of integrated protein data , 2011, Database J. Biol. Databases Curation.
[18] P. Visscher,et al. GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.
[19] Ralf Herwig,et al. ConsensusPathDB: toward a more complete picture of cell biology , 2010, Nucleic Acids Res..
[20] Jana Marie Schwarz,et al. MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.
[21] Tanya M. Teslovich,et al. Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.
[22] Yun Li,et al. METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..
[23] F. Zitman,et al. Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA). , 2010, The Journal of clinical psychiatry.
[24] T. Lehner,et al. The Netherlands Twin Register Biobank: A Resource for Genetic Epidemiological Studies , 2010, Twin Research and Human Genetics.
[25] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[26] M. Beekman,et al. Nonagenarian Siblings and Their Offspring Display Lower Risk of Mortality and Morbidity than Sporadic Nonagenarians: The Leiden Longevity Study , 2009, Journal of the American Geriatrics Society.
[27] Justin C. Fay,et al. Identification of deleterious mutations within three human genomes. , 2009, Genome research.
[28] F. Collins,et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.
[29] P. Donnelly,et al. A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.
[30] Igor Rudan,et al. Runs of homozygosity in European populations. , 2008, American journal of human genetics.
[31] P. Cuijpers,et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods , 2008, International journal of methods in psychiatric research.
[32] Ronald P. Stolk,et al. Universal risk factors for multifactorial diseases-LifeLines : a three-generation population-based study , 2008 .
[33] Qiong Yang,et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. , 2007, American journal of epidemiology.
[34] Eric Boerwinkle,et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL , 2007, Nature Genetics.
[35] Danielle Posthuma,et al. Netherlands Twin Register: From Twins to Twin Families , 2006, Twin Research and Human Genetics.
[36] H. Towle,et al. ChREBP•Mlx Is the Principal Mediator of Glucose-induced Gene Expression in the Liver* , 2006, Journal of Biological Chemistry.
[37] J. Repa,et al. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. , 2006, Cell metabolism.
[38] Milton H. Saier,et al. TCDB: the Transporter Classification Database for membrane transport protein analyses and information , 2005, Nucleic Acids Res..
[39] Marian Beekman,et al. Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study , 2006, European Journal of Human Genetics.
[40] H. Towle. Glucose as a regulator of eukaryotic gene transcription , 2005, Trends in Endocrinology & Metabolism.
[41] J. Girard,et al. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. , 2005, Biochimie.
[42] René Veenstra,et al. Evaluation of non-response bias in mental health determinants and outcomes in a large sample of pre-adolescents , 2005, European Journal of Epidemiology.
[43] M. Magnuson,et al. Hepatic Glucokinase Is Required for the Synergistic Action of ChREBP and SREBP-1c on Glycolytic and Lipogenic Gene Expression* , 2004, Journal of Biological Chemistry.
[44] G. Pasterkamp,et al. Athero-express: Differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design , 2004, European Journal of Epidemiology.
[45] A. M. George,et al. The ABC transporter structure and mechanism: perspectives on recent research , 2004, Cellular and Molecular Life Sciences CMLS.
[46] Ron D. Appel,et al. ExPASy: the proteomics server for in-depth protein knowledge and analysis , 2003, Nucleic Acids Res..
[47] P. Macfarlane,et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.
[48] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[49] D. Grobbee,et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity , 2001, Journal of internal medicine.
[50] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[51] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[52] P. Macfarlane,et al. The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. , 1999, The American journal of cardiology.
[53] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..
[54] J. Naylor,et al. Mendelian inheritance in man: A catalog of human genes and genetic disorders , 1996 .
[55] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[56] W. Kannel,et al. AN APPROACH TO LONGITUDINAL STUDIES IN A COMMUNITY: THE FRAMINGHAM STUDY , 1963, Annals of the New York Academy of Sciences.